Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Practice guidelines and clinical risk assessment models: is it time to reform?

  • Nariman Sepehrvand1Email author,
  • Firouz Ghaderi Pakdel2,
  • Mohammad Hosein Rahimi-Rad3,
  • Babak Moosavi-Toomatari1 and
  • Shahrzad Bazargan-Hejazi4
BMC Medical Informatics and Decision Making201111:63

DOI: 10.1186/1472-6947-11-63

Received: 4 January 2011

Accepted: 18 October 2011

Published: 18 October 2011

Abstract

Background

Clinical practice guidelines and Risk Assessment Models (RAMs) are some useful tools to bring medical evidences into our daily clinical practice. Despite the improvement over the time, they still have some shortcomings.

Discussion

One of these shortcomings is the arbitrary cutoffs used in these tools to facilitate the decision making process. This problem is to some extent due to the "Black or White" approach of modern medicine in making the decisions, whilst in the real world and our daily practice we used mostly an uncertain approach, which is called recently as "Fuzzy" thinking approach.

Summary

The authors of this article believe that the fuzzy type of thinking may resolve the above mentioned shortcomings of clinical practice guideline or risk assessment models and they tried to discuss about this using an example about Venous Thromboembolism related guidelines and RAMs.

Keywords

Practice guidelines Risk assessment models Fuzzy Logic Venous Thromboembolism

Background

Clinical practice guidelines are useful decision support tools in the process of carrying medical evidences to the point of practice [1]. An example for an important health system problem which experiences a gap between medical evidences and clinical practice is venous thromboembolism (VTE) [2].

Several practice guidelines have developed and focused on this topic, among which the most important one is the evidence-based VTE prevention practice guideline generated and updated by the American College of Chest Physicians (ACCP) [3]. This guideline proposes clinical decision making regarding identification and screening of thromboprophylaxis according to the presence of risk factors in various patient groups. This method of risk evaluation, underestimates the risk of venous thromboembolism in some cases [4]. However this guideline in a section mentioned the individual patient risk assessment and advocates for the use of clinical judgment in some specific circumstances [3].

Despite development of various Practice guidelines for prevention of Venous Thromboembolism (VTE), it remains underused in most countries [5, 6]. Improving clinician's compliance with the guidelines is a complex task and partly rest on improving thrombotic risk-assessment methods [7]. There are several risk assessment tools for VTE prevention, from which the three most notable models were developed by Caprini, Cohen, and Kucher [4, 8, 9]. These models considered the individualized approach to the VTE risk determination in each patient [3]. These risk assessment models (RAM) consist of a list of exposing risk factors (presenting illness or procedure) and predisposing risk factors (genetic and clinical characteristics), each with an assigned relative risk score [4, 10]. As stated in the 8th annual conference of ACCP and the earlier editions of the ACCP guideline, the VTE risk factors are generally cumulative [3, 11]. In another words, scores for each risk factor are summed to produce a cumulative score, and is used to classify a patient into one of the four risk categories and determine the onset, intensity, type, and duration of recommended prophylaxis [12].

The 8th ACCP conference on VTE prevention, allocated a section to the aforementioned risk assessment models [3] criticizing these models for being cumbersome, and not validated adequately. On the other hand several studies in the past few years have validated the Caprini risk assessment model and linked the score to the eventual development of clinically relevant VTE events up to 60 days post discharge [1315]. While the original model put people in 4 groups, the validation studies have shown that for each increase in score, the incidence of VTE rises [13]. At the same time, the important role of these models in developing a computerized decision making support systems for clinicians was discussed. Clinical informatics and electronic health records have the potential to ease application of risk assessment model [7].

Another major critique pointed out by the later edition of ACCP guideline regarding the risk assessment models, is the arbitrary cutoffs for age and duration of surgery [3]. We are aimed in this article to suggest a way to address this critique of ACCP guideline to RAMs.

Discussion

We (the authors) do not confine this shortcoming of RAMs (i.e arbitrary cutoffs) only to age or the duration of surgery as noted by the ACCP guideline. Many other risk factors such as Body Mass Index (BMI), history of major surgery, Stroke, multiple trauma, hip, pelvic and leg fractures in one month prior to hospitalization may have such problem in determining the total VTE risk of an individual.

An example may clarify the issue: a 61 years old man with a history of major surgery of cholecystectomy in the past year is admitted to your hospital with a progressive stroke. Also, another patient, a 74 years old woman with a history of Coronary Artery Bypass Graft (CABG) in the past year, is admitted with a mild Transient Ischemic Attack (TIA). The point score for both two patients using the Caprini Risk Assessment model is 8 and includes 1 for the history of major surgery, 2 for age, and 5 for stroke during the month prior to hospitalization for the first patient, and 2 for age, 4 for history of CABG, and at least 2 for admission with TIA for the second one. The patients acquired equal scores for their ages, but are 61 and 74 years old equal in predisposing VTE? According to the Caprini model, patients between 41-60 years old are assigned one score, and patients between 61-74 years old are assigned 2 score for VTE risk [4]. What is the real difference between 59 and 61 years old, which 1 was assigned for one of them and 2 was assigned for the other? This problem is due to mentioned arbitrary cutoff points which were addressed in the 8th ACCP practice guideline too. How were these cutoff points determined? The cutoff points for age, length of surgery, and BMI were determined over the past 25 years and have solid bases in the literature [11, 16]. Also several studies have validated these data (cutoff points which were applied in risk assessment models) and confirmed the use of them to predict the 60 day clinically relevant VTE event [1315].

Cutoff points are the corner stones and also the flaw of medical guidelines (even evidence-based guidelines). A patient with a body temperature more than 37.2°C axillary in the morning is considered as febrile, but is there a significant difference between 37.1 and 37.3°C, to consider one as febrile and the other one as afebrile? The complex mind of the human does not work like this (with a binary pattern) during its daily interpretations or decision makings.

The authors of this article believe that, this problem of risk assessment models (i.e. arbitrary cutoffs) can be corrected using fuzzy logic in decision making process.

Fuzzy logic which was first introduced by Lotfi A. Zadeh in 1965, transcends the "black and white" approach of the Aristotelian logic, and tries to capture the wide grey areas of imprecision in between [17]. This logic provides a mathematical approach to interpret the grey zones of imprecision.

Considering the imprecise nature of the individual's personal and physical characteristics, Lotfi A. Zadeh anticipated that medicine probably would be the main domain for the application of his theory [18]. But despite this prominent forecast, its progression in the field of medicine remained slow [19].

In recent years interesting proposals for the application of fuzzy logic in medical sciences have been appeared in the literature [2022], and in this regard a special mention has to be made to the contributions coming from the group of Helgason, aiming for example to better individualize diagnostic process [23], or prescribing and dosing of particular medications at the bedside [24, 25].

A new approach to medicine which has had a rapid and continuing growth in the field is the practice of evidence-based medicine (EBM) [26]. The ACCP guidelines for VTE prophylaxis were provided by this evidence-based approach. Some authors consider EBM and Fuzzy logic as two sides of a same coin. The authors of this article believe that fuzzy logic approach is not in contrast to the evidence-based medicine approach, but it is a complementary tool for a more realistic approach to the practice of evidence-based medicine. Fuzzy logic by capturing the grey zone in medical decision makings increases the reliability of risk assessment models. The probabilistic approach of the Fuzzy logic amplifies the applicability of electronic alerts and computerized decision-support systems.

Medical guidelines and risk assessment models capture clinical findings (history or physical examination) and para-clinical findings [12] in the process of determining medical decision. However, as was mentioned above, most of these findings in reality cannot project a binary (black or white) approach. Consider "Swollen legs" in a physical exam: In fuzzy manner of thinking, every body has "swollen legs" to some degree. This degree of membership is almost zero for normal and healthy people, and maybe near 1 for patients with 4+ pitting edema in legs.

ACCP guideline declared "there is little formal understanding of how the various risk factors interact in a quantitative manner to determine the position of each patient along a continuous spectrum of thromboembolic risk"[3]. Indeed, this is a particular case of fuzzy thinking model. In fuzzy manner of thinking, the risk of VTE rest on a continuum. The input from risk assessment models (or even practice guidelines) could be fuzzified for variables that are compatible with this way of thinking. In fuzzy logic, partial antecedents result in partial implications. As a consequence, the output of these risk assessment models will be a fuzzy variable with a degree of membership in each of two neighbor options. Then the outcome (output) of this system could be defuzzified to identify which option is more preferable.

By merging and concurrent use of these two approaches (EBM and Fuzzy logic) in the process of decision-making, fuzzy logic can yield its suitable place in the field of medicine, considering the rapidly progression of evidence-based medicine in this field.

It seems that lack of adequate validity studies, limited number of thromboprophylaxic options, or the complexity of using these risk assessment models for physicians is not enough to burying risk assessment models, and advocating for the simple approach (risk of each patient group) used by ACCP guideline. Fuzzy-based computerized decision support systems can resolve most of the ACCP guidelines shortcomings.

Patients with lower levels of VTE risk may be more affected by using the fuzzy manner of thinking, because among these patients, the application of fuzzy logic may alter the risk level and the options of thromboprophylaxis due to change in cumulative risk score.

The total risk score of patients with higher risk levels (risk score > 7 in Caprini model) may be decreased to some extent using the fuzzy approach, but the option of thromboprophylaxis is similar to when the fuzzy logic is not applied.

As discussed above, a reform in the field of risk assessment tools is needed to enhance their applicabilities in accordance with the expectations of clinicians, as the natural fuzzy thinking systems.

Summary

The application of Fuzzy thinking model in developing decision support systems can resolve most of the shortcomings of risk assessment models and practice guidelines.

List of Abbreviations

RAM: 

Risk Assessment Model

ACCP: 

American College of Chest Physicians

VTE: 

Venous Thromboembolism

EBM: 

Evidence-Based Medicine

BMI: 

Body Mass Index

TIA: 

Transient Ischemic Attack

CABG: 

Coronary Artery Bypass Graft

Declarations

Acknowledgements

The authors would like to thank Students' Research Committee of Urmia University of Medical Sciences for the grants provided for our study.

Authors’ Affiliations

(1)
Students' Research Committee, Urmia University of Medical Sciences
(2)
Department of Physiology, Urmia University of Medical Sciences
(3)
Department of Internal Medicine, Imam-Khomeini Training Hospital, Urmia University of Medical Sciences
(4)
Department of Psychiatry, Charles Drew University of Medicine and Science, & David Geffen School of Medicine, University of California

References

  1. Toussi M, Lamy JB, Le Toumelin P, Venot A: Using data mining techniques to explore physicians' therapeutic decisions when clinical guidelines do not provide recommendations: methods and example for type 2 diabetes. BMC Med Inform Decis Mak. 2009, 9: 28-10.1186/1472-6947-9-28.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG: Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126 (3 Suppl): 338S-400S.View ArticlePubMedGoogle Scholar
  3. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest P: Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008, 133 (6 Suppl): 381S-453S. 10.1378/chest.08-0656.View ArticlePubMedGoogle Scholar
  4. Caprini JA: Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005, 51 (2-3): 70-78. 10.1016/j.disamonth.2005.02.003.View ArticlePubMedGoogle Scholar
  5. Awidi A, Obeidat N, Magablah A, Bsoul N: Risk stratification for venous thromboembolism in hospitalized patients in a developing country: a prospective study. J Thromb Thrombolysis. 2009, 28 (3): 309-313. 10.1007/s11239-008-0291-1.View ArticlePubMedGoogle Scholar
  6. Rahimi-Rad MH, Moshiri Z: Thromboprophylaxis Practice in Teaching Hospital Settings. Tanaffos. 2006, 5 (2): 21-26.Google Scholar
  7. Caprini JA, Hyers TM: Compliance with antithrombotic guidelines. Manag Care. 2006, 15 (9): 49-50. 53-60, 66.PubMedGoogle Scholar
  8. Cohen A, Alikhan R, Arcelus J: A risk assessment model for identifying medical patients who should receive thromboprophylaxis [abstract]. J Thromb Haemost. 2003, 1 (Supp): OC437-Google Scholar
  9. Kucher N, Koo S, Quiroz R: Electronic alerts to prevent venous thromboembolism among hospitalized patients. Journal of Vascular Surgery. 2005, 42 (1): 178-View ArticleGoogle Scholar
  10. Caprini JA, Arcelus JI, Reyna JJ: Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001, 38 (2 Suppl 5): 12-19.View ArticlePubMedGoogle Scholar
  11. Anderson FA, Spencer FA: Risk factors for venous thromboembolism. Circulation. 2003, 107 (23 Suppl 1): I9-16.PubMedGoogle Scholar
  12. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA: A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method. Ann Surg. 2009Google Scholar
  13. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA: A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method. Ann Surg. 2010, 251 (2): 344-350. 10.1097/SLA.0b013e3181b7fca6.View ArticlePubMedGoogle Scholar
  14. Hatef DA, Kenkel JM, Nguyen MQ, Farkas JP, Abtahi F, Rohrich RJ, Brown SA: Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008, 122 (1): 269-279. 10.1097/PRS.0b013e3181773d4a.View ArticlePubMedGoogle Scholar
  15. Seruya M, Venturi ML, Iorio ML, Davison SP: Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg. 2008, 122 (6): 1701-1708. 10.1097/PRS.0b013e31818dbffd.View ArticlePubMedGoogle Scholar
  16. Nicolaides AN, Bergqvist D, Hull R: Prevention of venous thromboembolism - International Consensus Statement (Guidelines According to Scientific Evidence). Int Angiol. 1997, 16 (1): 3-38.Google Scholar
  17. Torres A, Nieto JJ: Fuzzy logic in medicine and bioinformatics. J Biomed Biotechnol. 2006, 2006 (2): 1-7.View ArticleGoogle Scholar
  18. Zadeh L: Biological application of the theory of fuzzy sets and systems. Proc Int Symp Biocybernetics of the central nervous system: 1969; Boston. 1969, Little & Brown Co, 199-212.Google Scholar
  19. Steimann F: Fuzzy set theory in medicine. Artif Intell Med. 1997, 11 (1): 1-7.PubMedGoogle Scholar
  20. Grossi E: Medical concepts related to individual risk are better explained with "plausibility" rather than "probability". BMC Cardiovasc Disord. 2005, 5: 31-10.1186/1471-2261-5-31.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Massad E, Ortega NR, Struchiner CJ, Burattini MN: Fuzzy epidemics. Artif Intell Med. 2003, 29 (3): 241-259. 10.1016/S0933-3657(02)00070-2.View ArticlePubMedGoogle Scholar
  22. Pagliaro L: Probabilistic and fuzzy logic in the clinical diagnosis. Intern Emerg Med. 2007, 2 (2): 75-10.1007/s11739-007-0039-5. discussion 100 - 106.View ArticlePubMedGoogle Scholar
  23. Helgason CM, Jobe TH: Fuzzy logic and causal reasoning with an 'n' of 1 for diagnosis and treatment of the stroke patient. Expert Rev Neurother. 2004, 4 (2): 249-254. 10.1586/14737175.4.2.249.View ArticlePubMedGoogle Scholar
  24. Helgason CM: The application of fuzzy logic to the prescription of antithrombotic agents in the elderly. Drugs Aging. 2004, 21 (11): 731-736. 10.2165/00002512-200421110-00003.View ArticlePubMedGoogle Scholar
  25. Helgason CM, Jobe TH: Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients. Curr Treat Options Cardiovasc Med. 2005, 7 (3): 211-218. 10.1007/s11936-005-0049-4.View ArticlePubMedGoogle Scholar
  26. Straus SE, Richardson WS, Glasziou P, Haynes RB: Evidence-Based Medicine: How to Practice and Teach EBM. 2005, Philadelphia, USA: Elsevier, Churchill Livingstone, 3Google Scholar
  27. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6947/11/63/prepub

Copyright

© Sepehrvand et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement